Medical Device Utilizing Saliva for Concussion Screening

The project involves developing a medical device to detect the clinically validated concussion biomarker, S100B. The intern’s work focuses on creating a device that can identify a specific threshold of this biomarker, crucial for identifying concussion risk. This research offers HeadFirst a unique opportunity to understand the potential of S100B in saliva for concussion diagnosis, potentially revolutionizing the industry with groundbreaking insights.
Moreover, this project is a vital starting point for our ongoing concussion research. Experience gained here, along with data and knowledge, will drive future investigations into various concussion biomarkers, allowing us to refine diagnostic techniques and potentially uncover new markers. This commitment places HeadFirst at the forefront of concussion diagnosis advancements, strengthening our reputation as a field leader, and contributing to enhanced concussion management and care.

Faculty Supervisor:

William Anderson

Student:

Partner:

HeadFirst

Discipline:

Engineering

Sector:

Manufacturing

University:

University of Waterloo

Program: